Timed-release localized drug delivery by percutaneous administra

Surgery – Means for introducing or removing material from body for... – Treating material introduced into or removed from body...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

604 57, 604 49, 424424, A61M 3100

Patent

active

058938397

ABSTRACT:
Devices and methods are disclosed for the percutaneous administration of a composition to a desired in vivo location. The composition comprises a biologically active substance and a pharmaceutically acceptable carrier. The pharmaceutically acceptable carrier is preferably non-solid and a polymer, which is preferably capable of being transformed into a gel, thus allowing timed-released delivery of the substance. A preferred use for this invention is to provide local delivery of biologically active substances for the prevention of restenosis following angioplasty or other blood vessel injury.

REFERENCES:
patent: 4898734 (1990-02-01), Mathiowitz et al.
patent: 5100668 (1992-03-01), Edelman et al.
patent: 5116864 (1992-05-01), March et al.
patent: 5171217 (1992-12-01), March et al.
patent: 5290267 (1994-03-01), Zimmermann
patent: 5487739 (1996-01-01), Aebischer et al.
patent: 5575015 (1996-11-01), Slepian et al.
patent: 5605696 (1997-02-01), Eury et al.
Edelman et al., "Effect of Controlled Adventitial Heparin Delivery on Smooth Muscle Cell Proliferation following Endothelial Injury," Proc. Natl. Acad. Sci. USA, Medical Sciences, May 1990, vol. 87, pp. 3773-3777.
Rogers et al., "Controlled Release of Heparin Reduces Neointimal Hyperplasia in Stented Rabbit Arteries: Ramifications for Local Therapy," Journal of Interventional Cardiology, Mar. 3, 1992, vol. 5, No. 3, pp. 195-202.
Rogers, et al., "Inhibition of Experimental Neointimal Hyperplasia and Thrombosis Depends on the Type of Vascular Injury and the Site of Drug Administration," Circulation, May 17, 1993; vol. 88, No. 3, pp. 1215-1221.
Hill, et al., "Inhibition of Thrombosis and Intimal Thickening by in situ Photopolymerization of Thin Hydrogel Barriers," Proc. Natl. Acad. Sci. USA, Medical Services, Jun. 1994, vol. 91, pp. 5967-5971.
Slepian, Marvin J., "Polymeric Endoluminal Paving: A Family of Evolving Methods for Extending Endoluminal Theropeutics Beyond Stenting," Cardiology Clinics, Nov. 1994, vol. 12, No. 4, pp. 715-737.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Timed-release localized drug delivery by percutaneous administra does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Timed-release localized drug delivery by percutaneous administra, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Timed-release localized drug delivery by percutaneous administra will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-222595

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.